Page 12 - Cannabis News April 2019
P. 12

Thinking About Adding Medical Marijuana Referral to Your Practice?



          Every Florida physician who serves as                                             ices). Accordingly, physi-  into, and will enhance, his or her prac-
        the primary care provider (“PCP”) for                                               cians in general, and PCPs   tice.
        some or all of his or her patients should                                           particularly, can minimize
        consider whether to become a “Qualified                                             the likelihood of patients
        Ordering Physician” (“QOP”), with the                                               looking elsewhere for a      Mr. Siegel and Ms. Hibnick are Partners
        ability to authorize Qualified Patients                                             QOP, or asking the physi-  in the Coral Gables office of Lubell/Rosen, a
        (“QP”) to receive medical marijuana                                                 cian for a referral to a QOP,   full-service law firm that focuses on serving
        (“cannabis”). Physicians in a number of                                             thereby losing some or all                 the legal needs of the
        specialties (i.e., pain management and                                              their business. Becoming a                healthcare community.
        oncology) are recognizing the value of                                              QOP not only strengthens
        cannabis for treating their QPs’ medical                                            the “stickiness” of current   Mr. Siegel has been recognized as Board
        issues and are becoming QOPs.                                                       patients, it may likely    Certified in Health Law by The Florida Bar.
          The number of Floridians who are QPs                                              attract additional patients      He also is certified by the HCCB in
        and using cannabis continues to grow        BY STEPHEN H. SIEGEL, ESQ. AND          whose PCPs have not          Healthcare Compliance and Healthcare
        exponentially. According to the Office of   CYNTHIA BARNETT HIBNICK, ESQ.           adopted   this  business      Privacy Compliance. He is a member of
        Medical Marijuana Use (“OMMU”), one                                                 model.                             Lubell |Rosen’s Health Law and
        year ago, on March 16, 2018, there were                                               For both clinical and     CannabisLAW Groups. He can be reached
        88,154 QPs. By March 15, 2019, that   ing medical marijuana in Florida. Many   economic reasons (as well as a minimal   at 305.298.8640 or shs@lubellrosen.com.
        number had more than doubled to      of these conditions are treated by most   capital investment), becoming a QOP is
        194,997 QPs. During that same time   PCPs; for example, cancer, glaucoma,   an attractive option for many physicians.   Ms. Hibnick chairs Lubell |Rosen’s
        period, the number of QOPs grew from   Crohn’s disease, multiple sclerosis, and   Achieving this designation adds both   CannabisLAW Group and also is a member
        1,225 to 2,106, again nearly doubling the   chronic nonmalignant pain.   another treatment modality and a new   of the firm’s Health Law Group. She can be
        number of QOPs in just one year. Besides   Patients no longer are passive   revenue stream. Working with legal and        reached at 305.671.7771 or
        the obvious economic reasons to consid-  observers of their medical conditions.   other advisors, every Florida PCP should     cbh@lubellrosen.com.
        er becoming a QOP, there are compelling   Many patients will decide to try medical   evaluate whether becoming a QOP fits
        clinical reasons to seriously consider   marijuana. They will either seek a QOP
        adding cannabis to your treatment rec-  on their own or ask their PCPs for refer-
        ommendations to your patients.       rals. Either way, there is likely to be some
                                             level of disruption in those patients’
        Clinical Perspective                 plans of treatment. Possibly the best way
          Along with “do no harm”, a funda-  to avoid this disruption is for patients to
        mental principle of any medical practice   receive or have supervised all their med-
        is to alleviate a patient’s pain and suffer-  ical care by one physician--their PCP.

        ing to the extent possible. It is entirely   Economic Perspective
        feasible that the debate about the efficacy
        and safety of cannabis may never be   Physician income from providing tra-
        resolved definitively (although clinical   ditional clinical services is flat, at best,
        and epidemiological studies in Europe   or, more likely, stagnating. Physicians in
        do support reported improvement in   general, and PCPs in particular, cannot
        patients’ conditions, particularly with the   render more services or increase their
        elderly). See Epidemiological character-  rates in order to cover the gap between
        istics, safety and efficacy of medical   reality and their expectations.
        cannabis in the elderly, European Journal   PCPs recognize patient retention is
        of Internal Medicine, March 2918,    critical to their financial success.
        Volume 49, pp 44-50; https://www.ejin-  Regardless of whether patient payments
        me.com/article/S0953-6205(18)30019-  are made by fee-for-service, capitated,
        0/fulltext. Although there is a dearth of   global fee, or some other basis, a loyal
        clinical and epidemiological studies in   and stable base of patients is necessary
        the United States, due in part by the clas-  for a physician to succeed in private
        sification of cannabis as a Schedule I   practice. In order to develop patients
        drug, the anecdotal evidence suggests   who look to their PCPs for guidance and
        that, at a minimum, using cannabis can   direction in making clinical decisions
        alleviate a patient’s pain, epileptic   (“sticky patients”), medical practices
        episodes, nausea from chemotherapy,   have adopted satisfaction surveys and
        etc. Consequently, the number of     other measures that recognize that
        patients seeking this treatment, and the   patients are not only medical care seek-
        number of physicians who are permitted   ers, but also customers and have the
        to authorize it, are predicted to continue   same expectations as customers in other
        to increase greatly.                 industries.
          The Florida Legislature recognized   In order to develop and maintain
        that cannabis has value in treating a wide   “sticky patients”, physicians should offer
        range of patients when it incorporated   patients as many medical services as they
        thirteen (13) “qualifying medical condi-  require from one source (of course,
        tions” into the statutory scheme regulat-  assuming that source is appropriately
                                             medically qualified to provide such serv-


                                     www.CannabisNewsFlorida.com
             Visit us on the web at www.CannabisNewsFlorida.com




        Cannabis News Florida                                                                          cannabisnewsflorida.com                                                                  April 2019                          41
   7   8   9   10   11   12   13   14   15   16   17